Perfluorohexyloctane and lotilaner ophthalmic solution, 2 ocular surface disease drugs, have changed the DED and DB treatment paradigms.
Capping ten years of work to stem the tide of nearsightedness, David Berntsen, Golden-Golden Professor of Optometry and chair ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback